Published in Gene Therapy Weekly, May 13th, 2004
As the first company enabling individuals to bank their own stem cells for future medical treatments, Chao brings to NeoStem a wealth of experience in stem cell and cancer research, and BMT. As a NeoStem medical advisory board member, he will provide professional counsel to the company, with a focus on clinical trials, adult stem-cell research, and new therapeutic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.